GRO BIOSCIENCES INC

Biotech · Private

Modified insulin analogs produced via in vivo protein production platform with non-standard amino acids for once-weekly dosing

Grants
$1.4M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
16
1 granted · 15 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Synthetic biology platform for production of stabilized high-value proteins$225,000
Federal grantNational Science Foundation · Phase II · SBIR Phase II: Synthetic biology platform for production of stabilized high-value proteins$1,199,999
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1909Regranion, LLC——
1910Yobee Care, Inc.—$1.4M
1911Wise Trading Technologies, Inc.—$85K
1912GRO BIOSCIENCES INC——
1913SET THERAPEUTICS INC——
1914Cogent Biosciences——
1915RIPARIAN PHARMACEUTICALS INC—$500K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 16
  • Non-standard Amino Acid Containing Compositions And Uses Thereofapplication
  • Non-standard Amino Acid Containing Compositions And Uses Thereofgranted
  • Human Dnase For Lung Diseaseapplication
  • Modified Polypeptides And Methods Of Making Or Uses Thereofapplication
  • Polypeptide Compositions Containing Non-standard Glycan Stub Amino Acids And Methods Of Making And Uses Thereofapplication
  • Compositions And Methods Of Use For Inteinsapplication
  • Polypeptide Compositions Containing Non-standard Glycan Amino Acids And Methods Of Making And Uses Thereofapplication
  • Diselenide-stabilized Feed Enzymesapplication
  • Human Dnase For Lung Diseaseapplication
  • Non-standard Amino Acid Containing Compositions And Uses Thereofapplication
  • Diselenide-stabilized Feed Enzymesapplication
  • Human Dnase For Lung Diseaseapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.